Nothing Special   »   [go: up one dir, main page]

EA201591680A1 - Смесь жирных кислот (гжк, группа жирных кислот) и её применение для лечения воспалительных патологий - Google Patents

Смесь жирных кислот (гжк, группа жирных кислот) и её применение для лечения воспалительных патологий

Info

Publication number
EA201591680A1
EA201591680A1 EA201591680A EA201591680A EA201591680A1 EA 201591680 A1 EA201591680 A1 EA 201591680A1 EA 201591680 A EA201591680 A EA 201591680A EA 201591680 A EA201591680 A EA 201591680A EA 201591680 A1 EA201591680 A1 EA 201591680A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
gls
application
acid mixture
fatty acids
Prior art date
Application number
EA201591680A
Other languages
English (en)
Other versions
EA035091B1 (ru
Inventor
Лодовико Бураттин
Original Assignee
Эген Лайф Италия Срл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201591680(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эген Лайф Италия Срл filed Critical Эген Лайф Италия Срл
Publication of EA201591680A1 publication Critical patent/EA201591680A1/ru
Publication of EA035091B1 publication Critical patent/EA035091B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение относится к смеси как минимум трех жирных кислот, выбранных из пальмитиновой, олеиновой, стеариновой, линолевой, альфа-линоленовой, гамма-линоленовой, эйкозапентаеновой (ЭПК), докозагексановой (ДГК), азелаовой и миристиновой кислот. Изобретение также относится к применению вышеупомянутой смеси для лечения воспалительных патологий.
EA201591680A 2013-03-08 2014-03-04 Смесь жирных кислот (гжк, группа жирных кислот) и её применение для лечения воспалительных патологий EA035091B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
PCT/EP2014/054163 WO2014135529A1 (en) 2013-03-08 2014-03-04 Mixture of fatty acids for use in the treatment of inflammatory pathologies

Publications (2)

Publication Number Publication Date
EA201591680A1 true EA201591680A1 (ru) 2015-12-30
EA035091B1 EA035091B1 (ru) 2020-04-27

Family

ID=48227394

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201791885A EA036724B1 (ru) 2013-03-08 2014-03-04 Смесь жирных кислот и её применение для лечения воспалительных патологий
EA201591680A EA035091B1 (ru) 2013-03-08 2014-03-04 Смесь жирных кислот (гжк, группа жирных кислот) и её применение для лечения воспалительных патологий

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201791885A EA036724B1 (ru) 2013-03-08 2014-03-04 Смесь жирных кислот и её применение для лечения воспалительных патологий

Country Status (18)

Country Link
US (2) US11020365B2 (ru)
EP (2) EP2964215B1 (ru)
AU (2) AU2014224710B2 (ru)
CA (1) CA2904112C (ru)
CY (2) CY1122248T1 (ru)
DK (2) DK3219316T3 (ru)
EA (2) EA036724B1 (ru)
ES (2) ES2779851T3 (ru)
HK (1) HK1243924A1 (ru)
HR (2) HRP20191963T1 (ru)
HU (2) HUE046239T2 (ru)
IT (1) ITMI20130354A1 (ru)
LT (2) LT3219316T (ru)
PL (2) PL3219316T3 (ru)
PT (2) PT2964215T (ru)
RS (2) RS59523B1 (ru)
SI (2) SI2964215T1 (ru)
WO (1) WO2014135529A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
DK3177281T3 (da) * 2014-08-08 2024-03-11 Ali Res S R L Blanding af fedtsyrer og palmitoylethanolamid til brug i behandlingen af betændelses og allergiske patologier
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
CN112469406B (zh) * 2018-05-31 2024-05-17 财团法人峨山社会福祉财团 硬脂酸用于预防或治疗肺纤维化的用途
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
EP4103145A4 (en) * 2020-02-12 2024-07-03 Retrotope Inc DEUTERATED POLYUNSATURATED FATTY ACIDS OR THEIR ESTERS FOR COSMETIC APPLICATIONS
WO2023018703A1 (en) * 2021-08-09 2023-02-16 Kentucky Equine Research, Inc. Compositions and methods for modulating equine fatty acid profiles
WO2023097296A1 (en) * 2021-11-24 2023-06-01 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107663T3 (es) * 1992-04-28 1997-12-01 Fresenius Ag Empleo de una emulsion que contiene acidos grasos omega-3 en la fabricacion de un medicamento a administrar por via parenteral para el tratamiento de las enfermedades inflamatorias.
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
EP1175901B1 (en) * 1999-04-15 2006-05-31 Kaneka Corporation Peroxisome activator-responsive receptor agonists
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
ES2300399T3 (es) 2002-04-30 2008-06-16 Cognis Ip Management Gmbh Empleo de mezclas de principios activos con acido acelaico y acido glicirretico como agentes anti-acne.
US7612111B2 (en) * 2003-03-20 2009-11-03 Imagenetix, Inc. Esterified fatty acid composition
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
US8765661B2 (en) * 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8372425B2 (en) * 2008-10-31 2013-02-12 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
DK2429317T4 (da) 2009-04-17 2019-05-13 Natac Pharma S L Sammensætninger med højt indhold af omega-3-fedtsyrer og med lavt indhold af phytansyre
PL2796129T3 (pl) * 2009-09-07 2015-11-30 Epitech Group S P A Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
SI2661266T1 (sl) 2011-01-07 2021-01-29 Anji Pharma (Us) Llc Terapije, na osnovi kemosenzoričnih receptorskih ligandov
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
AU2014224710B2 (en) 2018-04-12
CY1122248T1 (el) 2020-11-25
EP3219316B1 (en) 2020-02-19
DK3219316T3 (da) 2020-03-16
DK2964215T3 (da) 2019-11-11
SI3219316T1 (sl) 2020-07-31
WO2014135529A1 (en) 2014-09-12
PL3219316T3 (pl) 2020-06-01
AU2018202190A1 (en) 2018-04-26
CY1122783T1 (el) 2021-05-05
PT3219316T (pt) 2020-03-27
CA2904112C (en) 2021-03-23
US20210290578A1 (en) 2021-09-23
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
LT2964215T (lt) 2019-11-25
PL2964215T3 (pl) 2020-03-31
ITMI20130354A1 (it) 2014-09-09
SI2964215T1 (sl) 2019-12-31
EA036724B1 (ru) 2020-12-11
EP3219316A1 (en) 2017-09-20
EA201791885A1 (ru) 2018-01-31
RS60023B1 (sr) 2020-04-30
US20160015666A1 (en) 2016-01-21
LT3219316T (lt) 2020-04-10
HUE048361T2 (hu) 2020-08-28
HRP20200394T1 (hr) 2020-06-12
EP2964215B1 (en) 2019-08-21
PT2964215T (pt) 2019-11-12
RS59523B1 (sr) 2019-12-31
CA2904112A1 (en) 2014-09-12
AU2014224710A1 (en) 2015-09-10
HRP20191963T1 (hr) 2020-01-24
EA035091B1 (ru) 2020-04-27
AU2018202190B2 (en) 2019-05-02
US11020365B2 (en) 2021-06-01
ES2779851T3 (es) 2020-08-20
EP2964215A1 (en) 2016-01-13
HK1243924A1 (zh) 2018-07-27

Similar Documents

Publication Publication Date Title
EA201591680A1 (ru) Смесь жирных кислот (гжк, группа жирных кислот) и её применение для лечения воспалительных патологий
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
EA201400152A1 (ru) Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции, содержащие жирные кислоты, и способы их получения и применения
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
PE20170431A1 (es) Lipido que comprende acido docosapentaenoico
ZA201704820B (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
WO2014074552A3 (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
MX356427B (es) Emulsion que contiene hormona.
CO2017001088A2 (es) Mezcla de ácidos grasos y palmitoiletanolamida para su uso en el tratamiento de patologías inflamatorias y alérgicas
GEP201606568B (en) Compositions for the treatment of neurologic disorders
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
MY177028A (en) Solid compositions of triglycerides and uses thereof
MX2016006675A (es) Producción de ácidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa de pufa proveniente de traustoquitridio.
MX2015007085A (es) Composiciones de acido omega-3 pentanoico y metodos de uso.
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
TW201613571A (en) OMWGA-3 compositions, dosage forms, and methods of use
PL3560342T3 (pl) Kompozycje wielonienasyconych kwasów tłuszczowych wzbogacone w dha
MX2015011508A (es) Produccion de acidos grasos omega-3 a partir de la especie pythium.
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
MX358743B (es) Fluidos dielectricos a base de trigliceridos no oleicos de baja viscosidad con alto punto de inflamacion.
MX358901B (es) Fluidos dielectricos de alto punto de inflamabilidad, baja viscosidad, basados en trigliceridos.
MY182731A (en) Fat composition
GB201607617D0 (en) Use of EPA and DHA Omega3 Dietary supplementation and Omega6 polyunsaturated fatty acid dietary restriction to cure 2 type diabetes